$LMNL Short the crap. Tight stop-lossLook left NASDAQ:LMNL on daily.
All the pumps followed by the dumps next day.
Close below open - 78%
Avg. fade - 17%
Avg. low - 28%
We aim 23% on the backside here.
844.95 KUSD
308.02 KUSD
283.19 K
About Liminal BioSciences Inc.
Sector
Industry
CEO
Bruce Philip Pritchard
Website
Headquarters
Laval
Employees (FY)
43
Founded
1994
Liminal BioSciences, Inc. operates as a clinical stage biopharmaceutical company. The firm focuses on developing distinctive novel small molecule therapeutics for inflammatory, fibrotic, and metabolic diseases using drug discovery platform and a data driven approach. The firm has business operations in Canada and the United Kingdom. Its small molecule product candidate, fezagepras, has completed a Phase 1 multi-ascending dose clinical trial and anticipate conducting a comparative Phase 1a single ascending dose clinical trial to provide comparative data to support development plan. The company was founded on October 14, 1994 and is headquartered in Laval, Canada.
Tangent school: LMNL BuyLimit@4.99 Break through the trend lineTangent school: LMNL BuyLimit@4.99 Break through the trend line
LMNLI called Liminal BioSciences Inc (NASDAQ:LMNL) recently at $4.40 as a potential big runner due to the PDUFA catalyst. On Friday, just a few minutes before the close, the stock was halted and the U.S. Food & Drug Administration (FDA) announced the approval of Ryplazim® (plasminogen, human-tvmh) ("Ry
LMNL up and awaynew catalyst on 4 th of june, FDA approval on ryplazim. this stock has been very weak for a while now. big movement imminent on monday
LMNL to double or quadruple within 6-12 months?DISCLAIMER: I'm not a certified or licensed financial advisor, securities trader, or securities broker; and, this is not intended as financial or securities advice.
Hopefully, my observations are improving. Using two separate 2 over 2 layouts for my version of multiple time frame analysis . Trackin
mid term +6,000%Liminal BioSciences Inc., a clinical-stage biopharmaceutical company, focuses on discovery, development, and commercialization of novel small molecule drug candidates for the treatment of patients suffering from respiratory fibrotic diseases and other fibrotic or inflammatory diseases that have high
Liminal BioSciences, a risky play85% below the July peak of last year and 99% below its all-time high.
Orbiting a major support level around $4.
A capital injection began in mid-November that is still not properly reflected in price.
Stochastic at the oversold point and RSI close to touching it.
It could give the surprise of gi
LMNL subliminal chart messagesLMNL is a biopharma company of no incredible significance, but I thought the chart patterns were worth sharing. First and foremost, look at the runup in volume! Trapped beneath downtrend resistance, I'd venture to guess it's undergoing heavy accumulation. If it breaks through downtrend resistance,
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Frequently Asked Questions
The current price of LMNL is 8.50 USD — it has increased by 0.12% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Liminal BioSciences Inc. stocks are traded under the ticker LMNL.
Liminal BioSciences Inc. is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
LMNL stock is 0.24% volatile and has beta coefficient of 1.82. Check out the list of the most volatile stocks — is Liminal BioSciences Inc. there?
LMNL earnings for the last quarter are −2.80 USD per share, whereas the estimation was −1.60 USD resulting in a −75.00% surprise. The estimated earnings for the next quarter are −1.01 USD per share. See more details about Liminal BioSciences Inc. earnings.
Liminal BioSciences Inc. revenue for the last quarter amounts to 184.21 K USD despite the estimated figure of 154.96 K USD. In the next quarter revenue is expected to reach 568.23 K USD.
Yes, you can track Liminal BioSciences Inc. financials in yearly and quarterly reports right on TradingView.
No, LMNL doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, LMNL shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Liminal BioSciences Inc. stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 24, 2024, the company has 43.00 employees. See our rating of the largest employees — is Liminal BioSciences Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Liminal BioSciences Inc. technincal analysis shows the buy rating today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Liminal BioSciences Inc. stock shows the neutral signal. See more of Liminal BioSciences Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.